SBI Securities Co., Ltd.
Broker-DealerPosition in ACHV — Achieve Life Sciences, Inc.
CIK 1851815
TOKYO, M0
Position in ACHV
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$41,480
-$28,303 QoQ
Shares Held
14,109
+0.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 81 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SBI Securities Co., Ltd. holds $11,510,394 across 406 Biotechnology names. ACHV ranks #27 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
39,686 | $1,903,737 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
156,604 | $1,201,152 | |
| 3 | GYRE |
Gyre Therapeutics, Inc.
|
170,837 | $1,190,733 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
31,615 | $1,028,752 | |
| 5 | MRNA |
Moderna, Inc.
|
16,795 | $853,186 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
242,617 | $744,834 | |
| 7 | BNTX |
BioNTech SE
|
6,346 | $564,032 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,237 | $552,369 |
All Filings in ACHV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,480 | 14,109 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $69,783 | 14,041 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $44,226 | 14,040 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $31,691 | 14,023 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $37,441 | 14,023 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $49,360 | 14,023 | Shares | Defined | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||